Comparison between Gland Pharma IPO and Likhitha Infrastructure IPO.
Gland Pharma IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Likhitha Infrastructure IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Likhitha Infrastructure IPO is up to ₹61.20 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Likhitha Infrastructure IPO is ₹120.00 per share.
| Gland Pharma IPO | Likhitha Infrastructure IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,490.00 per share | ₹116.00 per share |
| Issue Price (Upper) | ₹1,500.00 per share | ₹120.00 per share |
| Issue Price (Final) | ₹1,500.00 per share | ₹120.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 10 shares | 125 shares |
| Fresh Issue Size | 83,33,333 shares | 51,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹1,250.00 Cr | up to ₹61.20 Cr |
| OFS Issue Size | 3,48,63,635 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹5,229.55 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,31,96,968 shares | 51,00,000 shares |
| Issue Size Total (Amount) | up to ₹6,479.55 Cr | up to ₹61.20 Cr |
Gland Pharma IPO opens on Nov 09, 2020, while Likhitha Infrastructure IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Likhitha Infrastructure IPO is Nov 11, 2020, and Oct 07, 2020, respectively.
| Gland Pharma IPO | Likhitha Infrastructure IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2020 | |
| Issue Open | Nov 09, 2020 | Sep 29, 2020 |
| Issue Close | Nov 11, 2020 | Oct 07, 2020 |
| Basis Of Allotment (Tentative) | Nov 17, 2020 | Oct 12, 2020 |
| Initiation of Refunds (Tentative) | Nov 18, 2020 | Oct 13, 2020 |
| Credit of Share (Tentative) | Nov 19, 2020 | Oct 14, 2020 |
| Listing date (Tentative) | Nov 20, 2020 | Oct 15, 2020 |
| Anchor Lockin End date 1 | Dec 17, 2020 | |
| Anchor Lockin End date 2 | Feb 15, 2021 |
Gland Pharma IPO P/E ratio is , as compared to Likhitha Infrastructure IPO P/E ratio of .
| Gland Pharma IPO | Likhitha Infrastructure IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 74 | 99.96 | ||||
| Promoter Shareholding (Post-Issue) | 58 | 74.11 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹24492.42 Cr. | ₹236.70 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Gland Pharma IPO Retail Individual Investors (RII) are offered 1,51,18,939 shares while in Likhitha Infrastructure IPO retail investors are offered 1,51,18,939 shares. Qualified Institutional Buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 51,000 shares in Likhitha Infrastructure IPO.
| Gland Pharma IPO | Likhitha Infrastructure IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,29,59,089 shares | |
| Market Maker Reservation | ||
| QIB | 86,39,394 shares | 51,000 shares |
| NII | 64,79,546 shares | 32,64,000 shares |
| RII | 1,51,18,939 shares | 17,85,000 shares |
| Employee | ||
| Others | ||
| Total | 4,31,96,968 shares | 51,00,000 shares |
Gland Pharma IPO subscribed 2.06x in total, whereas Likhitha Infrastructure IPO subscribed 9.51x.
| Gland Pharma IPO | Likhitha Infrastructure IPO | |
|---|---|---|
| QIB (times) | 6.40x | 21.99x |
| NII (times) | 0.51x | 1.54x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.24x | 23.71x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.06x | 9.51x |
